These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35731850)

  • 1. Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast.
    Kamau A; Musau M; Mwakio S; Amadi D; Nyaguara A; Bejon P; Seale AC; Berkley JA; Snow RW
    Clin Infect Dis; 2023 Feb; 76(3):e875-e883. PubMed ID: 35731850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
    J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya.
    Mutanyi JA; Onguru DO; Ogolla SO; Adipo LB
    Infect Dis Poverty; 2021 Aug; 10(1):106. PubMed ID: 34362443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
    Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
    PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana.
    Orish VN; Onyeabor OS; Boampong JN; Afoakwah R; Nwaefuna E; Acquah S; Sanyaolu AO; Iriemenam NC
    Afr Health Sci; 2015 Dec; 15(4):1087-96. PubMed ID: 26958008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.
    Waltmann A; McQuade ETR; Chinkhumba J; Operario DJ; Mzembe E; Itoh M; Kayange M; Puerto-Meredith SM; Mathanga DP; Juliano JJ; Carroll I; Bartelt LA; Gutman JR; Meshnick SR
    EBioMedicine; 2022 Mar; 77():103871. PubMed ID: 35217408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.
    Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL
    Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaqunine Against Malaria in Pregnancy in Tanzania: A Randomized Controlled Trial.
    Mlugu EM; Minzi O; Kamuhabwa AAR; Aklillu E
    Clin Pharmacol Ther; 2021 Dec; 110(6):1478-1489. PubMed ID: 33891721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.